trial summary · NCT07659678
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
Trial record from the TrialBase DB dataset, status RECRUITING, condition Head and Neck Squamous Cell Carcinoma, sponsored by Washington University School of Medicine. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).
Source record: https://clinicaltrials.gov/study/NCT07659678
Facts
| registry id | NCT07659678 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | Head and Neck Squamous Cell Carcinoma |
| sponsor | Washington University School of Medicine |
| sponsor class | OTHER |
| enrollment | 90 |
| start date | 2026-10-31 |
| primary completion | 2032-05-31 |
| completion | 2032-05-31 |
| results posted | not reported |
Conditions
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
- Head and Neck Squamous Cell Carcinoma HNSCC
Interventions
- 64Cu-DOTA-ECL1i
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.